
Organic Process Research and Development p. 1385 - 1392 (2012)
Update date:2022-07-29
Topics:
Mobele, Bingidimi I.
Venkatraman, Sripathy
McNaughton-Smith, Grant
Gibb, Cameron
Ulysse, Luckner G.
Lindmark, Carl A.
Shaw, Stephen
Marron, Brian
Spear, Kerry
Suto, Mark J.
A scalable process for the manufacture of a potassium ion channel blocker was developed and optimized. Key features of the process include an optimized Grignard reaction, a direct cyanation of the intermediate trityl alcohol derivative, and an improved nitrile hydrolysis protocol, relative to the original acidic hydrolysis conditions, to generate the crude active pharmaceutical ingredient (API) with >95% HPLC purity. The Grignard and the cyanation reactions could be telescoped, resulting in an improved throughput compared to the original four-step process. An effective recrystallization of the API was also developed and the process scaled up to manufacture multiple batches at the pilot scale.
View MoreHANGZHOU TOYOND BIOTECH CO., LTD
Contact:+86-571-86965177
Address:No. 189, Fengqi East Road, Hangzhou, China
Anyang Double Circle Auxiliary CO.,LTD
Contact:0086-134 6082 4403
Address:dongfeng road, anyang city, henan province,china
Wuhan Fortuna Chemical Co.,Ltd
website:http://www.fortunachem.com
Contact:86-27-59207850
Address:Add: Room 2015, No.2 Building, Kaixin Mansion No.107 Jinqiao Avenue, Wuhan, China
Beijing Green Guardee Technology CO,.LTD
Contact:+86-10-69706062
Address:F2 BLdj,5 No.37 Chaoqian Road
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Doi:10.1007/s10600-012-0257-6
(2012)Doi:10.1039/c2dt30719g
(2012)Doi:10.1021/jo00034a050
(1992)Doi:10.1021/cg300757k
(2012)Doi:10.1016/j.tetlet.2012.06.050
(2012)Doi:10.1016/j.molstruc.2012.02.037
(2012)